June 23, 2009: Neural Fair Value Portfolio for Investment Ideas

Amidst the commentary, sometimes investors just need a list of ideas to contemplate. The Standard and Poors' Neural Fair Value Portfolio, updated regularly, provides for the investor a list of their top 25 companies that are considered to have superior price appreciation potential. The Neural roster has generally outperformed the S&P500Index by a significant margin.

Naturally, this list is for your use to begin inquiry into whether one or more of these recommendations will be suitable for your portfolio. Without elaboration, here it is:

Accenture, Ltd. (ACN)
ADC Telecommunications (ADCT)
Allergan, Inc. (AGN)
Immucor, Inc. (BLUD)
BMC Software, Inc. (BMC)
Check Point Software Technologies, Inc. (CHKP)
Capella Education (CPLA)
General Dynamics (GD)
Hanesbrands (HBI)
Herbalife, Ltd. (HLF)
International Business Machines Corp. (IBM)
Lockheed Martin Corp. (LMT)
Macy's, Inc. (M)
NetApp, Inc. (NTAP)
Occidental Petroleum Corp. (OXY)
Petsmart, Inc. (PETM)
Polycam, Inc. (PLCM)
QLogic Corp (QLGC)
Symantec Corp. (SYMC)
Tidewater, Inc. (TDW)
Integrys Energy Group, Inc. (TEG)
Hanover Insurance, Inc. (THG)
Tempur Pedic International, Inc. (TPX)
Tyco International, Ltd. (TYC)

None of these are presently in my portfolios.